Featuring the experiences of an open science advocate in pharma, an analysis of open science and diversity, an undergraduate peer-reviewed journal, the lessons learnt from COVID-19, alternatives to journal impact factors and a machine-learning approach to big data.
Featuring the need for digital preservation of journals, COVID-19 and the evolving research landscape, a ‘historic pledge’ from pharma regarding the COVID-19 vaccine race, the use of academic social networks, an analogy for data sharing and the monetary value of publications.
Featuring an open letter from pharma, the theme of Open Access Week 2020, a new publishing partnership between Hindawi and SAGE Publishing, a metrics-based study on open access and social media engagement, a call for systematizing journal databases and directories, discussions regarding sustainable open source alternatives and Molecular Biology of the Cell’s transition to a Subscribe To Open subscription model.
Featuring Green Templeton College’s mini-symposium, discussions of gender equity in academic publishing, UCL’s COVID-19 research platform, the #BetterPoster campaign, a new read-and-publish deal between the Max Planck Society and AIP Publishing, and the evolution of Executable Research Articles.
Featuring discussions of open scholarship, plain language summaries of publications, support for rapid reviews of COVID-19 preprints, the Arabian Citation Index, the outlook of open access, Brazilian publication policies and a celebration of HighWire.
Featuring discussions about patient partnerships in research, the curious case of MDPI, rapid reviews of COVID-19 preprints, metrics of open access papers, recognition for research contributors, the implementation of new editorial procedures and a publisher’s steps towards open access.
Featuring the impact COVID-19 could have on evidence-based medicine, the use of open science and the economic landscape of publishing, the results of a survey on attitudes towards preprints, the first COVID-19 preprint index, the importance of open data to patients and a call for the revision of academic career progression.
Featuring the use of FAIR data principles for COVID-19 research, the recently published Hong Kong Principles, an update to the Declaration to Improve Biomedical & Health Research, a call to support universities with their open data, a collation of preprint review services, an assessment of clinical journals’ attitudes towards preprints and a case study outlining … Continue reading Weekly digest: what’s happening in open science?
Featuring the ERC’s decision to split from Plan S, a report on the Open Pharma June 2020 virtual roundtable meeting in BMJ Opinion, solutions for improving transparency, the Data Ethics Canvas tool, Beck et al.’s recommendations for preprint server best practice, a concerning increase in citation rates for journals discontinued from the Scopus database and … Continue reading Weekly digest: what’s happening in open science?
Featuring the new cOAlition S Rights Retention Strategy, an analysis of institutional open access output, subjectivity in peer review reports, insights on opening up science to the public, appeals against Clarivate’s blacklist decision and concerns of questionable editorial practices. The new Rights Retention Strategy via cOAlition S To ensure the compliance of exclusive publishing agreements … Continue reading Weekly digest: what’s happening in open science?